MedTrace Logo

Isoflavones and the Coronary Circulation in Men and Women With Coronary Artery Disease

NCT00287690 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2019-08-05

Study results available
· View outcomes & findings →

Summary

The aim of this study is to investigate the effect of genistein administration on coronary arteries in humans. We will measure the size of a coronary artery and the speed and amount of blood flow in response after subjects have ingested Supro® drinks (a soy protein drink containing genistein).

Conditions

Interventions

DRUG

Genistein

Drink taken once daily

DRUG

Placebo

Drink taken once daily

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Peter Collins, MD, FRCP · Imperial College London

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-10-31
Primary Completion
2003-08-18
Completion
2003-08-18

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00287690 on ClinicalTrials.gov